Skip to main content

Advertisement

Autocrine loops

Article metrics

  • 408 Accesses

Misregulation of autocrine signalling loops may contribute to cancer phenotypes. In the Advanced Online Publication of Nature Genetics, Graeber and Eisenberg of the Howard Hughes Medical Institute and the University of California, Los Angeles describe a computer-based strategy to identify receptor-ligand pairs and autocrine loops in large datasets (29 October 2001, DOI: 10.1038/ng755). They compiled a Database of Ligand-Receptor Partners (DLRP) that is based on the published literature and contains 452 ligand-receptor pairs. They then used this information to screen several published datasets of microarray expression profiling in cancer samples, and measured the correlation coefficient between ligand and receptor expression profiles. Graeber and Eisenberg identified ligand-receptor partners previously implicated in autocrine signalling (for example, inerleukin (IL) 10 and its receptor and tumor necrosis factor (TNF) and its receptors), and propose some new effectors (including several chemokines, such as CCL4 and the CCR5 receptor). These results await experimental confirmation that this strategy can predict receptor-ligand pairs that are relevant to cancer.

References

  1. 1.

    Autocrine growth factors and cancer

  2. 2.

    Nature Genetics, [http://genetics.nature.com]

  3. 3.

    Howard Hughes Medical Institute , [http://www.hhmi.org]

  4. 4.

    University of California, Los Angeles , [http://www.ucla.edu]

  5. 5.

    Database of Interacting Proteins, [http://dip.doe-mbi.ucla.edu]

Download references

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Weitzman, J.B. Autocrine loops. Genome Biol 2, spotlight-20011101-01 (2001) doi:10.1186/gb-spotlight-20011101-01

Download citation

Keywords

  • CCL4
  • Medical Institute
  • Cancer Sample
  • Microarray Expression
  • Experimental Confirmation